Answer
Women of childbearing potential should use effective contraception throughout treatment with bevacizumab gamma and for at least three months after the last dose when stopping treatment.
Sources for this answer
- Lytenava 25 mg/mL solution for injectionOutlook Therapeutics Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 4Document updated
Sources checked